
Ankit D. Tejani
Examiner (ID: 3986, Phone: (571)272-5140 , Office: P/3766 )
| Most Active Art Unit | 3766 |
| Art Unit(s) | 3792, 3766, 3762, 3796 |
| Total Applications | 855 |
| Issued Applications | 650 |
| Pending Applications | 110 |
| Abandoned Applications | 110 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18985669
[patent_doc_number] => 20240057638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => COMPOSITIONS FOR REDUCING METHANE EMISSION, METHODS FOR IMPROVING THE METABOLIC EFFICIENCY OF RUMINANT ANIMALS AND METHANOGENESIS INHIBITOR ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/268263
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18268263
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/268263 | COMPOSITIONS FOR REDUCING METHANE EMISSION, METHODS FOR IMPROVING THE METABOLIC EFFICIENCY OF RUMINANT ANIMALS AND METHANOGENESIS INHIBITOR ADMINISTRATION | Dec 20, 2021 | Pending |
Array
(
[id] => 19241079
[patent_doc_number] => 12011495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Long wear liquid anhydrous composition
[patent_app_type] => utility
[patent_app_number] => 17/557105
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4459
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557105
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557105 | Long wear liquid anhydrous composition | Dec 20, 2021 | Issued |
Array
(
[id] => 19001984
[patent_doc_number] => 20240066055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => FATTY ACID-MODIFIED POLYMER NANOPARTICLES, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/269543
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269543
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269543 | FATTY ACID-MODIFIED POLYMER NANOPARTICLES, AND USE THEREOF | Dec 20, 2021 | Pending |
Array
(
[id] => 17670793
[patent_doc_number] => 20220183960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => DEODORANT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/553648
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553648 | DEODORANT COMPOSITIONS | Dec 15, 2021 | Abandoned |
Array
(
[id] => 18412009
[patent_doc_number] => 11666536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Extended release compositions comprising pyridostigmine
[patent_app_type] => utility
[patent_app_number] => 17/550117
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 27
[patent_no_of_words] => 33768
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17550117
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/550117 | Extended release compositions comprising pyridostigmine | Dec 13, 2021 | Issued |
Array
(
[id] => 17609652
[patent_doc_number] => 20220151931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => ANTICANCER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/549495
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/549495 | ANTICANCER COMPOSITIONS | Dec 12, 2021 | Abandoned |
Array
(
[id] => 17609609
[patent_doc_number] => 20220151888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => SUGAR-FREE LIP SCRUB COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/526266
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17526266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/526266 | SUGAR-FREE LIP SCRUB COMPOSITIONS AND USES THEREOF | Nov 14, 2021 | Abandoned |
Array
(
[id] => 18860108
[patent_doc_number] => 20230414542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => ORALLY DISPERSIBLE COMPOUND CONTAINING AN ESTER OR SALT OF N-BUTYRIC ACID AND PROCESS FOR PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/036482
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036482
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036482 | ORALLY DISPERSIBLE COMPOUND CONTAINING AN ESTER OR SALT OF N-BUTYRIC ACID AND PROCESS FOR PRODUCTION | Nov 11, 2021 | Pending |
Array
(
[id] => 19510393
[patent_doc_number] => 20240342079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => COMPOSITIONS FOR NASAL APPLICATION
[patent_app_type] => utility
[patent_app_number] => 18/251018
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251018 | COMPOSITIONS FOR NASAL APPLICATION | Nov 2, 2021 | Pending |
Array
(
[id] => 18901240
[patent_doc_number] => 20240016725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => SOLIDIFIED LIP GLOSS STICK-TYPE COSMETIC COMPOSITION STABILIZING HIGH-CONTENT OLIGOMER-TYPE PHYTOSTEROL ESTERS
[patent_app_type] => utility
[patent_app_number] => 18/038501
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038501
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038501 | SOLIDIFIED LIP GLOSS STICK-TYPE COSMETIC COMPOSITION STABILIZING HIGH-CONTENT OLIGOMER-TYPE PHYTOSTEROL ESTERS | Oct 28, 2021 | Pending |
Array
(
[id] => 17561610
[patent_doc_number] => 20220125759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => METHODS OF INCREASING MAGNESIUM BIOAVAILABILITY AND ABSORPTION
[patent_app_type] => utility
[patent_app_number] => 17/513276
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513276 | Methods of increasing magnesium bioavailability and absorption | Oct 27, 2021 | Issued |
Array
(
[id] => 18893642
[patent_doc_number] => 20240009127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => METHODS AND COMPOSITIONS FOR NUTRITIONAL SUSTENANCE AND WASTE SCAVENGING IN TISSUE INJURIES AND WOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/250459
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250459
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250459 | METHODS AND COMPOSITIONS FOR NUTRITIONAL SUSTENANCE AND WASTE SCAVENGING IN TISSUE INJURIES AND WOUNDS | Oct 26, 2021 | Pending |
Array
(
[id] => 18860075
[patent_doc_number] => 20230414509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => HYDROPHOBIC DRUGS IN ORGANIC CORE HIGH DENSITY LIPOPROTEIN (HDL) NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/032201
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032201
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032201 | HYDROPHOBIC DRUGS IN ORGANIC CORE HIGH DENSITY LIPOPROTEIN (HDL) NANOPARTICLES | Oct 21, 2021 | Pending |
Array
(
[id] => 17398030
[patent_doc_number] => 20220040120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/507369
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17507369
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/507369 | PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TREATMENT | Oct 20, 2021 | Abandoned |
Array
(
[id] => 18829535
[patent_doc_number] => 20230398059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => OIL-BASED COSMETIC
[patent_app_type] => utility
[patent_app_number] => 18/033144
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033144
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033144 | OIL-BASED COSMETIC | Oct 17, 2021 | Abandoned |
Array
(
[id] => 18312721
[patent_doc_number] => 20230116621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => DRUG DELIVERY CARRIER INCLUDING PLGA AND BETA-CYCLODEXTRIN CONTAINING DRUG
[patent_app_type] => utility
[patent_app_number] => 17/502181
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502181
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502181 | DRUG DELIVERY CARRIER INCLUDING PLGA AND BETA-CYCLODEXTRIN CONTAINING DRUG | Oct 14, 2021 | Abandoned |
Array
(
[id] => 20644640
[patent_doc_number] => 12599565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Stable benzimidazole formulation
[patent_app_type] => utility
[patent_app_number] => 17/501237
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2438
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501237
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501237 | Stable benzimidazole formulation | Oct 13, 2021 | Issued |
Array
(
[id] => 17532360
[patent_doc_number] => 20220110969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => Ready-To-Use Potassium Phosphates In Sodium Chloride Solutions
[patent_app_type] => utility
[patent_app_number] => 17/499001
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499001 | Ready-to-use potassium phosphates in sodium chloride solutions | Oct 11, 2021 | Issued |
Array
(
[id] => 17355227
[patent_doc_number] => 20220016023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHOD FOR TREATING MYOPIA AND APPLICATION IN PREPARATION OF MEDICAMENT
[patent_app_type] => utility
[patent_app_number] => 17/490797
[patent_app_country] => US
[patent_app_date] => 2021-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17490797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/490797 | METHOD FOR TREATING MYOPIA AND APPLICATION IN PREPARATION OF MEDICAMENT | Sep 29, 2021 | Abandoned |
Array
(
[id] => 17805690
[patent_doc_number] => 20220257525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => DRUG DELIVERY SYSTEM FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/484725
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17484725
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/484725 | Drug delivery system for treatment of cancer | Sep 23, 2021 | Issued |